IRTC - iRhythm Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

iRhythm Technologies, Inc.

650 Townsend Street
Suite 500
San Francisco, CA 94103
United States

Full Time Employees748

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin M. KingPres, CEO & Director2.13M21.63M1956
Mr. Matthew C. GarrettChief Financial Officer943.21k3.55M1968
Mr. Karim KartiChief Operating Officer2.52MN/A1969
Mr. David A. VortExec. VP of Sales802.18k304.38k1966
Mr. Mark J. Day Ph.D.Exec. VP of R&D656.12k5.46M1971
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.

Corporate Governance

iRhythm Technologies, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.